Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycythemia Vera 10Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia 9Glioblastoma 9Leukemia, Myeloid, Acute 8Meningioma 7Head and Neck Neoplasms 7Gliosarcoma 6Myelodysplastic Syndromes 4Glioma 4Central Nervous System Neoplasms 4Neoplasms 3Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Laryngeal Neoplasms 3Esophageal Neoplasms 3Treatment-Refractory Solid Tumors 2Thrombocythemia, Essential 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Oropharyngeal Neoplasms 2Myelodysplastic-Myeloproliferative Diseases 2Hypopharyngeal Neoplasms 2Congenital Abnormalities 2

Interventions

Radiation 1Paclitaxel 1Hydroxyurea 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HPV-Negative Squamous Cell Carcinoma × Hydroxyurea × Clear all
NCT06005324 2025-06-08

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

University of Chicago

Phase 1 Recruiting
36 enrolled

HPV-Negative Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡